Braskem (BAK) Cash & Current Investments (2009 - 2025)

Braskem (BAK) has reported Cash & Current Investments for 17 consecutive years, with $2.2 billion the latest figure, recorded in Q4 2025.

• Quarterly Cash & Current Investments fell 23.92% year-over-year to $2.2 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.2 billion (down 23.92% YoY) and the FY2025 annual result came in at $2.2 billion, down 23.92% from the prior year.
• Cash & Current Investments grew to $2.2 billion in Q4 2025 per BAK's latest filing, from $2.0 billion in the prior quarter.
• Over the last five years, Cash & Current Investments for BAK reached as high as $5.2 billion in Q4 2022 and fell as low as $2.0 billion in Q1 2025.
• A 5-year average of $3.2 billion and a median of $2.9 billion in 2024 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2021 — Cash & Current Investments slumped 35.6% — and 2022, when it surged 38.4%.
• Year by year, Cash & Current Investments stood at $3.7 billion in 2021, then soared by 38.4% to $5.2 billion in 2022, then declined by 25.33% to $3.9 billion in 2023, then declined by 25.37% to $2.9 billion in 2024, then dropped by 23.92% to $2.2 billion in 2025.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $2.2 billion, $2.0 billion, and $2.9 billion for Q4 2025, Q1 2025, and Q4 2024 respectively.